We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

2 hedge funds and large institutions have $3.44M invested in Albany Molecular Research Inc in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 133 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 136 → 2 (-134)

99% less capital invested

Capital invested by funds: $677M → $3.44M (-$674M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 133

Holders
2
Holders Change
-134
Holders Change %
-98.53%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
133
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AA
Ancora Advisors
Ohio
+$871K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$80M
2
ACM
American Capital Management
New York
-$55.9M
3
Deutsche Bank
Deutsche Bank
Germany
-$52M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$33.9M
5
Citigroup
Citigroup
New York
-$30.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
1
Ancora Advisors
Ohio
$2.97M +$871K +40,093 +42%
DekaBank Deutsche Girozentrale
2
DekaBank Deutsche Girozentrale
Germany
$468K – – –
BlackRock
3
BlackRock
New York
– -$80M -3,684,743 Closed
ACM
4
American Capital Management
New York
– -$55.9M -2,577,470 Closed
Deutsche Bank
5
Deutsche Bank
Germany
– -$52M -2,394,885 Closed
Vanguard Group
6
Vanguard Group
Pennsylvania
– -$33.9M -1,561,105 Closed
Citigroup
7
Citigroup
New York
– -$30.5M -1,404,192 Closed
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
– -$29.2M -1,346,341 Closed
WIC
9
Water Island Capital
New York
– -$23.5M -1,085,000 Closed
JP Morgan Chase
10
JP Morgan Chase
New York
– -$21.4M -987,235 Closed
CCM
11
Chicago Capital Management
Illinois
– -$21.4M -986,958 Closed
EWM
12
Evercore Wealth Management
New York
– -$19.2M -886,031 Closed
AA
13
AQR Arbitrage
Connecticut
– -$18.7M -862,379 Closed
WC
14
Walthausen & Co
New York
– -$17.9M -827,155 Closed
AAM
15
AMI Asset Management
California
– -$16M -735,876 Closed
Morgan Stanley
16
Morgan Stanley
New York
– -$12.9M -594,393 Closed
State Street
17
State Street
Massachusetts
– -$12.6M -579,404 Closed
OAM
18
Oxford Asset Management
United Kingdom
– -$10.7M -491,000 Closed
Allianz Asset Management
19
Allianz Asset Management
Germany
– -$9.61M -442,716 Closed
GCL
20
Glazer Capital LLC
New York
– -$9.5M -437,864 Closed
Bank of New York Mellon
21
Bank of New York Mellon
New York
– -$9.19M -423,337 Closed
RA
22
Royce & Associates
New York
– -$8.6M -396,275 Closed
OWP
23
Obermeyer Wealth Partners
Colorado
– -$8.11M -373,802 Closed
PCM
24
Prelude Capital Management
New York
– -$8M -368,504 Closed
Northern Trust
25
Northern Trust
Illinois
– -$7.72M -355,860 Closed
1
2 3 4 5

AMRI Hedge Fund Activity: Q3 2017 in Review

2 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q3 2017, worth a combined $3.44M — down 99% from $677M a quarter earlier.

Sellers outnumbered buyers: 133 funds closed out of AMRI and 0 opened new positions — a net loss of 133 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Ancora Advisors, adding an estimated $871K. The largest seller was BlackRock, exiting entirely with an estimated $80M sold.

  • 2 institutional investors held Albany Molecular Research Inc (AMRI) as of Q3 2017, down from 136 in Q2 2017.
  • Funds reported $3.44M of Albany Molecular Research Inc stock for Q3 2017, down 99% quarter-over-quarter.
  • 0 funds opened new Albany Molecular Research Inc positions in Q3 2017 and 133 closed out, a net change of -133 holders.
  • The largest Albany Molecular Research Inc buyer in Q3 2017 was Ancora Advisors, an estimated $871K added.
  • The largest Albany Molecular Research Inc seller in Q3 2017 was BlackRock, an estimated $80M sold.

Based on aggregated 13F filings for Q3 2017.